Citation only
via Europe PMC
Senescence-Associated Secretory Phenotype (SASP) and Atherosclerotic Plaque Inflammation: Natural Product-Based Interventions and Implications for Personalized Therapy.
Liu D, Kornthong N, Yu S, Tangthianchaichana J, Sobhon P, Yang S.
Cardiology research and practice · 2026
Deregulated nutrient-sensing
Cellular senescence
Altered intercellular communication
Chronic inflammation
Senolytics
Human
Mouse
Preclinical / animal
Review
Abstract
Atherosclerosis underlies most ischemic cardiovascular events, and its prevalence rises with population aging. Cellular senescence(definition) is increasingly implicated as a driver of plaque progression, although the causal evidence is largely preclinical. Senescent endothelial cells, smooth muscle cells, and macrophages acquire a senescence-associated secretory phenotype (SASP), releasing cytokines, chemokines, proteases, and procoagulant factors. These factors sustain plaque inflammation, weaken the fibrous cap, and increase rupture risk. In this narrative review, we link SASP signaling to plaque instability through NF-κB, p38 MAPK, mTOR(definition), NLRP3, and cGAS-STING signaling. We then evaluate tetramethylpyrazine (ligustrazine), quercetin, fisetin, resveratrol, and curcumin against an operational definition reserving senolytic and senomorphic for effects shown in confirmed senescent cells. On that standard, only quercetin and fisetin qualify; for the other three, the vascular evidence is anti-inflammatory, antioxidant, or senescence-preventive rather than directed at established senescent cells. Tetramethylpyrazine protects the endothelial glycocalyx and reduces plaque area in atherosclerotic rabbits. Dasatinib plus quercetin benefits ApoE-/- mice, whereas the only human evidence comes from quercetin monotherapy, which improved endothelium-dependent vasodilation in vessels from symptomatic male, but not female, bypass patients ex vivo. Because senescence burden varies between individuals, we consider how multiomics profiling might stratify patients. The evidence remains mechanistic and hypothesis-generating, with limited human cardiovascular interventional data: Much of it was recorded in cells never shown to be senescent, and no formulation has been shown to reach the human vessel wall. Targeting the SASP therefore requires trial evidence rather than an established basis for precision medicine.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- Europe PMC
- DOI
- 10.1155/crp/6765242
- Canonical
- link ↗
- Fetched
- 2026-11-14 MST
Cite this
APA
D, L., N, K., S, Y., J, T., P, S., & S., Y. (2026). Senescence-Associated Secretory Phenotype (SASP) and Atherosclerotic Plaque Inflammation: Natural Product-Based Interventions and Implications for Personalized Therapy. <em>Cardiology research and practice</em>. https://doi.org/10.1155/crp/6765242
Vancouver
D L, N K, S Y, J T, P S, S. Y. Senescence-Associated Secretory Phenotype (SASP) and Atherosclerotic Plaque Inflammation: Natural Product-Based Interventions and Implications for Personalized Therapy. Cardiology research and practice. 2026. doi:10.1155/crp/6765242.
BibTeX
@article{liu2026Senesc,
title = {Senescence-Associated Secretory Phenotype (SASP) and Atherosclerotic Plaque Inflammation: Natural Product-Based Interventions and Implications for Personalized Therapy.},
author = {Liu D and Kornthong N and Yu S and Tangthianchaichana J and Sobhon P and Yang S.},
journal = {Cardiology research and practice},
year = {2026},
doi = {10.1155/crp/6765242},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Cardiology Research and Practice 2026
Open access · CC-BY
Senescence‐Associated Secretory Phenotype (SASP) and Atherosclerotic Plaque Inflammation: Natural Product‐Based Interventions and Implications for Personalized Therapy
bioRxiv (Cold Spring Harbor Laboratory) 2025
Preprint · CC-BY
Senolytic treatment with fisetin reverses age-related endothelial dysfunction partially mediated by SASP factor CXCL12
Aging and Disease 2026
Open access · CC-BY
Gut Microbial Function and Immune Aging: An Evidence-Graded Framework Linking Microbial Metabolites to Healthspan and Age-Related Disease
PubMed Central 2019
Preprint · CC-BY
Senolytics and Senostatics: A Two-Pronged Approach to Target Cellular Senescence for Delaying Aging and Age-Related Diseases.
Ageing research reviews 2026
Citation only
Intracranial aneurysms as a manifestation of premature vascular aging: Cellular senescence, inflammaging, and wall degeneration.
BMB Reports 2015
Open access · CC-BY